Al
No verificado

Allurion Technologies, Inc.

Sobre qué escribimos

BiotecnologíaFitnessMaterial médico sanitarioSaludSanidad
12/01/2026
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Biotecnología
Fitness
Salud
Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results
1.00
25/11/2025
Salud
Material médico sanitario
Fitness
Sanidad
Medicina - Varios
Farmacéutica
Biotecnología
Industria
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence
1.00
12/11/2025
Biotecnología
Sanidad
Salud
Fitness
Web y redes sociales
Telefonía
Mercado de valores
Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update
1.00
11/11/2025
Finanzas
Industria
Acciones y Obligaciones
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Fitness
Medicina - Varios
Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing
1.00
06/11/2025
Salud
Sanidad
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025
1.00
30/09/2025
Salud
Material médico sanitario
Técnica
Fitness
Telefonía
Eventos
Allurion to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
1.00
13/08/2025
Material médico sanitario
Salud
Fitness
Sanidad
Biotecnología
Web y redes sociales
Telefonía
Mercado de valores
Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update
1.00

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0